Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AVELUMAB Cause C-reactive protein increased? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of C-reactive protein increased have been filed in association with AVELUMAB (BAVENCIO). This represents 0.3% of all adverse event reports for AVELUMAB.

10
Reports of C-reactive protein increased with AVELUMAB
0.3%
of all AVELUMAB reports
2
Deaths
5
Hospitalizations

How Dangerous Is C-reactive protein increased From AVELUMAB?

Of the 10 reports, 2 (20.0%) resulted in death, 5 (50.0%) required hospitalization.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AVELUMAB. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does AVELUMAB Cause?

Death (361) Disease progression (355) Off label use (200) Diarrhoea (153) Infusion related reaction (142) Pyrexia (129) Fatigue (124) Neoplasm progression (119) Dyspnoea (100) Nausea (99)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which AVELUMAB Alternatives Have Lower C-reactive protein increased Risk?

AVELUMAB vs AVIBACTAM AVELUMAB vs AVIBACTAM\CEFTAZIDIME AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE\TITANIUM DIOXIDE\ZINC AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE

Related Pages

AVELUMAB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased AVELUMAB Demographics